Pancreatic Cancer Research

ResearcherThe University of OsakaActive in the last 2 years

Ryota Sada

ORCID-verified (high confidence, 0.95), identity_conf@1As of 8 November 2026

Matched on ORCID iD 0000-0003-3403-0542; OpenAlex author ID A5024474932. Sources: OpenAlex.

Their work

Papers
2
Trials
0
Grants
0
Labs led
0
Collaborators
7
Papers, trials and grants by year

2019: 1 paper · 2020: none · 2021: none · 2022: none · 2023: none · 2024: 1 paper

Papers 2

  1. Newly developed humanized anti-CKAP4 antibody suppresses pancreatic cancer growth by inhibiting DKK1-CKAP4 signaling. Co-author DOI 10.1111/cas.16278↗
  2. CKAP4, a DKK1 Receptor, Is a Biomarker in Exosomes Derived from Pancreatic Cancer and a Molecular Target for Therapy. Co-author DOI 10.1158/1078-0432.ccr-18-2124↗

Closest collaborators

The 7 strongest of 7 by collab_strength@1: shared papers, trials and grants, recent and small-team work weighing most.

  1. Akira Kikuchi · 2 shared papers, 2019–2024 · strength 0.36
  2. Akikazu Harada · 1 shared paper, 2024 · strength 0.28
  3. Tsunekazu Mizushima · 1 shared paper, 2019 · strength 0.08
  4. Hidetoshi Eguchi · 1 shared paper, 2019 · strength 0.08
  5. Soichiro Mori · 1 shared paper, 2019 · strength 0.08
  6. Hirokazu Kimura · 1 shared paper, 2019 · strength 0.08
  7. Tetsuo Takehara · 1 shared paper, 2019 · strength 0.08

How to reach this person

A chain of introductions through people who have published, run trials or held grants together (warm_path@1: fewest links first, then the strongest). Built from public records only; no contact details are kept.